Well-Known Investor Says Robotaxis Will Prove to Be a Bad Business for TSLA

Larry Ramer

Wed, Apr 30, 2025, 7:22 AM 2 min read

Tesla (TSLA) volition learn" that robotaxis are not a worthwhile concern for it to enter,  Ross Gerber, the co-founder and CEO of Gerber Kawasaki Wealth & Investment Management precocious told  Bloomberg TV.

Gerber called Tesla's Q1 fiscal results "troubling" and suggested that the automaker volition not commencement turning itself astir until Elon Musk's nationalist representation improves.

Why Gerber Is Bearish connected Tesla's Robotaxi Efforts

Robotaxis are "highly competitive, and it's precise hard to get the bundle and hardware to enactment (for robotaxis)," Gerber said.

He added that TSLA had not yet been capable to make effectual hardware and bundle for its robotaxis

"In hindsight they mightiness truly miss selling EVs to people, since that's a increasing market," the seasoned capitalist added.

Gerber's Views connected TSLA's Results and Current Status

Tesla's automotive gross sank 20% past 4th versus the aforesaid play a twelvemonth earlier, Gerber noted.

He believes that lone by making consumers little aggravated astatine Elon Musk tin the steadfast meaningfully boost its automotive income going forward.

The Recent Price Action of TSLA Stock

In the past month, the shares person gained 7%, portion they person tumbled 30% successful the past 3 months.

While we admit the imaginable of TSLA, our condemnation lies successful the content that AI stocks clasp greater committedness for delivering higher returns, and doing truthful wrong a shorter timeframe. There is an AI banal that went up since the opening of 2025, portion fashionable AI stocks mislaid astir 25%. If you are looking for an AI banal that is much promising than TSLA but that trades astatine little than 5 times its earnings, cheque retired our study astir this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires Disclosure: None. This nonfiction is primitively published astatine Insider Monkey